Sort
35,931 grants matching “parkinsons”
A Novel Monkey Model for Parkinson's Drug Discovery
$1,949,249Howard J. Federoff · Georgetown University · RC2 · FY2010 · NS
Basal Ganglia in Health and Disease
$1,948,977Guohong Cui · National Institute Of Environmental Health Sciences · ZIA · FY2019 · ES
"Genetic and clinical studies of Gaucher disease and other lysosomal disorders"
$1,947,040Ellen Sidransky · National Human Genome Research Institute · ZIA · FY2011 · HG
Proteinopathies of the Aging Central Nervous System
$1,943,801Lennart Mucke · J. David Gladstone Institutes · P01 · FY2012 · AG
Genome wide SNP analysis in Neurological disorders
$1,943,649Andrew B Singleton · Aging · Z01 · FY2007 · AG
Functional Brain Networks: A Novel Approach to Address Clinical Challenges in PD
$1,942,247David Eidelberg · Feinstein Institute For Medical Research · P50 · FY2014 · NS
Fluorescence Microscopy
$1,942,001Charles Tucker · National Institute Of Environmental Health Sciences · ZIC · FY2022 · ES
Natl Resource for Mass Spectrom of Biolog Macromolecules
$1,941,711Brian T Chait · Rockefeller University · P41 · FY2007 · RR
Innate and Adaptive Immunity in Parkinson Disease
$1,940,771David G Standaert · University Of Alabama At Birmingham · P50 · FY2018 · NS
Degenerative and Dementing Diseases of Aging
$1,938,153Stanley B Prusiner · University Of California, San Francisco · P01 · FY2016 · AG
Mechanisms of Autophagy
$1,937,396Richard Youle · National Institute Of Neurological Disorders And Stroke · ZIA · FY2022 · NS
The Genetics of Parkinsonism
$1,937,376Duke University · P50 · FY2005 · NS
High-Field, Wide-Bore Solid-State NMR Spectrometer for Membrane Protein Structure
$1,936,449Chad M Rienstra · University Of Illinois At Urbana-Champaign · S10 · FY2008 · RR
COBRE GRANT
$1,936,240Jeffrey L. Cummings · Cleveland Clinic Foundation · P20 · FY2018 · GM
The UCLA UDALL Parkinson Disease Center of Excellence
$1,935,893Marie-Francoise S Chesselet · University Of California Los Angeles · P50 · FY2008 · NS
Feasibility of Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder
$1,934,626Ali R Rezai · West Virginia University · UH3 · FY2023 · DA
Development of selective amyloid-responsive fluorescent probes
$1,934,347Jerry Yang · University Of California, San Diego · RF1 · FY2022 · AG
Functional and Pharmacological Significance of Receptor Heteromers in the CNS
$1,932,282Sergi Ferre · National Institute On Drug Abuse · ZIA · FY2012 · DA
Innate and Adaptive Immunity in Parkinson Disease
$1,931,859David G Standaert · University Of Alabama At Birmingham · P50 · FY2019 · NS
Genetic characterization of atypical parkinsonism
$1,931,448Sonja Scholz · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS
The Morris K Udall Parkinson's Disease Research Center of Excellence
$1,929,516Ted M. Dawson · Johns Hopkins University · P50 · FY2013 · NS
HABS-HD - Core B - Neuroimaging & Informatics Core
$1,928,633Arthur W Toga · University Of North Texas Hlth Sci Ctr · U19 · FY2022 · AG
Examining the role of glycosphingolipids in the progression and heterogeneity of synucleinopathies
$1,928,426Joseph R Mazzulli · Northwestern University At Chicago · RF1 · FY2019 · NS
Innate and Adaptive Immunity in Parkinson Disease
$1,924,770David G Standaert · University Of Alabama At Birmingham · P50 · FY2020 · NS
Environmental and Genetic Risk Factors For Breast Cancer: The Sister Study
$1,922,443Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES